Clonatest

Immunoassay for the in vitro quantitative determination of total thyroxine in human serum and plasma.

Immunoassay for the in vitro quantitative determination of total thyroxine in human serum and plasma.

Immunoassay for in vitro quantitative determination of thyrotropin in human serum and plasma. The results can be used in the preliminary screening test of thyroid function

Immunoassay for in vitro quantitative determination of thyrotropin in human serum and plasma. The results can be used in the preliminary screening test of thyroid function

Immunoassay for the in vitro quantitative determination of antibodies to thyroglobulin in human serum and plasma. Determination of Anti-TG is used as an aid in the detection of autoimmune thyroid diseases.

Immunoassay for the in vitro quantitative determination of antibodies to thyroglobulin in human serum and plasma. Determination of Anti-TG is used as an aid in the detection of autoimmune thyroid diseases.

Immunoassay for in vitro quantitative determination of antibody to thyroid peroxidase in human serum and plasma. Clinically, it’s mainly used as an aid in diagnosis of hashimoto's thyroiditis and exophthalmic goiter.

Immunoassay for in vitro quantitative determination of antibody to thyroid peroxidase in human serum and plasma. Clinically, it’s mainly used as an aid in diagnosis of hashimoto's thyroiditis and exophthalmic goiter.

Immunoassay for the in vitro quantitative determination of N-terminal pro B-type natriuretic peptide in human plasma. Heart failure (HF) is complex clinical symptoms of lesion of myocardial structure and function, caused by myocardial infarction, cardiomyopathy, hypertension, inflammation and so on. The main manifestations are dyspnea, weakness and fluid retention, eventually leading to lowering the ventricular pumping and filling function. N-terminal pro B-type natriuretic peptide (NT-proBNP) and B-type natriuretic peptide (BNP) are recommended indicators of heart failure.

Immunoassay for the in vitro quantitative determination of N-terminal pro B-type natriuretic peptide in human plasma. Heart failure (HF) is complex clinical symptoms of lesion of myocardial structure and function, caused by myocardial infarction, cardiomyopathy, hypertension, inflammation and so on. The main manifestations are dyspnea, weakness and fluid retention, eventually leading to lowering the ventricular pumping and filling function. N-terminal pro B-type natriuretic peptide (NT-proBNP) and B-type natriuretic peptide (BNP) are recommended indicators of heart failure. STAT: used for immediate diagnostic testing in laboratories, providing quick and essential results for urgent medical situations.

Immunoassay for the in vitro quantitative determination of N-terminal pro B-type natriuretic peptide in human plasma. Heart failure (HF) is complex clinical symptoms of lesion of myocardial structure and function, caused by myocardial infarction, cardiomyopathy, hypertension, inflammation and so on. The main manifestations are dyspnea, weakness and fluid retention, eventually leading to lowering the ventricular pumping and filling function. N-terminal pro B-type natriuretic peptide (NT-proBNP) and B-type natriuretic peptide (BNP) are recommended indicators of heart failure. STAT: used for immediate diagnostic testing in laboratories, providing quick and essential results for urgent medical situations.

Immunoassay for in vitro quantitative determination of cardiac troponin I in human serum and plasma. This assay is intended to auxiliary diagnosis of myocardial infarction.